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Covid-19: ensuring equality of access to testing for
ethnic minorities
Programmes must ensure that “hard to reach” groups are no longer hardly reached
Catherine Dodds senior lecturer in public policy 1, Ibidun Fakoya research fellow 2
1School for Policy Studies, University of Bristol, Bristol, UK; 2School of Population Health and Environmental Sciences, King’s College London,
London, UK
Until successful vaccination programmes are in place
governments will be heavily reliant on widespread testing and
contact tracing to reduce the reproduction number of
SARS-CoV-2.1 Meanwhile international evidence continues to
emerge about ethnic disparities in covid-19 morbidity and
mortality,2 3 echoing the unequal burdens of other global
epidemics such as tuberculosis, hepatitis, and HIV. At this
crucial juncture, health and policy planners must ensure that
access to and uptake of SARS-CoV-2 testing is equitable across
all social and economic gradients. We support the recent call
for immediate inclusion of social scientists, anthropologists,
leaders of marginalised communities, and experts in local social
determinants of health in health policy making for this
pandemic4 so that sufficient access, trust, and cultural
competence are built in to test, track, and trace programmes for
covid-19.
Considerable international evidence exists on unequal uptake
of medical testing and surveillance across health
conditions—including assessment of cancer risk,5 antenatal
screening,6 and HIV testing.7 8 The disparity is largely
attributable to social determinants of health, coupled with
mistrust of medical institutions among those in marginalised
population groups. Without appropriate action, similar disparities
may hamper the success of covid-19 testing interventions.
Hostile environment and mistrust
The UK government is currently expanding its testing
programme through use of self-administered swab kits, a
strategy that should be informed by evidence on uptake of other
self-sampling kits among target groups. For example, a 2018
study found that use of HIV self-sampling kits among ethnic
minority target populations in the UK was low compared with
other groups.9 Our detailed investigations among black African
people in England and community health professionals revealed
mistrust of self-sampling technologies and yielded important
wider lessons about self-sampling.10 Such kits were reported to
be overcomplicated, with written instructions that were
inappropriate for those whose first language was not English;
were perceived as being unsafe for postal transfer; and were
regarded as unsuitable proxies for a sample handled by a health
professional in a secure and sterile setting. Although some of
our research participants thought that self-sampling was
appropriate for them, most said they were unlikely to use such
kits, with risks to privacy a key consideration.10
Health professionals often frame members of ethnic minority
communities as “hard-to-reach” because of low engagement in
population health screening. However, it is more accurate to
say these groups tend to be “hardly reached” by those who fail
to understand the needs of marginalised people who are asked
to send samples of bodily fluids to unknown others for
processing. A sociopolitical context where the UK government
continues to promote a hostile environment11 for “low skilled”
migrants,12 resulting in the wrongful denial of health services
to thousands13 only makes things worse. Given the
disproportionate and devastating impact this pandemic has
already had among our ethnic minority communities, such issues
need to be immediately addressed in the rollout of covid-19
screening.
Much work needs to be done to ensure populations at risk are
meaningfully prioritised for access to interventions for
SARS-CoV-2 testing. Policy makers must build trustworthy
surveillance programmes and give everyone the confidence that
they can access healthcare equitably during the covid-19
pandemic.14 Rolling out programmes for self-sampling without
regard for these experiences of exclusion will risk exacerbating
inequalities.
To help bridge this gap in trust, people from ethnic minorities
and their community representatives urgently need to be
included at the heart of national and local health planning. Good
planning will consider the need for tailored and multilingual
communications, relevant support from trained health
professionals, clarity about how samples and personal data are
handled, and assurances about free access to emergency
healthcare regardless of residency status or the NHS surcharge
for migrants.
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We urge policy makers to consider the potential harm that could
arise from rushed and poorly executed testing programmes that
exclude those groups at disproportionate risk of covid-19
morbidity and mortality. Planners at all levels should carefully
consider the interdisciplinarity of their response teams, so that
they are able to successfully confront the many challenges that
social, economic, and cultural inequality can pose in responses
to pandemics.
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